Export

EN
FR
Chloroquine
Essential medicine status
Section:
6. Anti-infective medicines 6.5. Antiprotozoal medicines 6.5.3. Antimalarial medicines 6.5.3.1. Antimalarial medicines > Medicines for curative treatment
ATC codes: P01BA01
EMLc
Indication
Malaria due to Plasmodium vivax ICD11 code: 1F81
INN
Chloroquine
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Additional notes
For use only for the treatment of P. vivax infection
Formulations
Oral > Liquid: 50 mg per 5 mL (base)
Oral > Solid > tablet: 150 mg (base)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1982 (TRS 685)
Changed in 1995 (TRS 867)
Changed in 2003 (TRS 920)
Changed in 2007 (TRS 946)
Changed in 2007 (TRS 950)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Chloroquine
DrugBank
Chloroquine
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - the deletion of chloroquine 100 mg tablets from the EML and EMLc; - to modify the formulation descriptions to describe strengths in terms of chloroquine base, without reference to the salt.